CN106755159A - A kind of liquor fermentation culture medium and the method for improving L tryptophan yield - Google Patents
A kind of liquor fermentation culture medium and the method for improving L tryptophan yield Download PDFInfo
- Publication number
- CN106755159A CN106755159A CN201611188743.1A CN201611188743A CN106755159A CN 106755159 A CN106755159 A CN 106755159A CN 201611188743 A CN201611188743 A CN 201611188743A CN 106755159 A CN106755159 A CN 106755159A
- Authority
- CN
- China
- Prior art keywords
- tryptophan
- fermentation medium
- acid
- production
- lysine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 title claims abstract description 92
- 238000000855 fermentation Methods 0.000 title claims abstract description 54
- 230000004151 fermentation Effects 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title claims abstract description 32
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 239000001963 growth medium Substances 0.000 title abstract description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 39
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 20
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims abstract description 20
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims abstract description 20
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000004472 Lysine Substances 0.000 claims abstract description 17
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 16
- 239000011573 trace mineral Substances 0.000 claims abstract description 16
- 239000004475 Arginine Substances 0.000 claims abstract description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 15
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000008103 glucose Substances 0.000 claims abstract description 15
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims abstract description 13
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims abstract description 11
- 235000019743 Choline chloride Nutrition 0.000 claims abstract description 11
- 229960003178 choline chloride Drugs 0.000 claims abstract description 11
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims abstract description 11
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims abstract description 10
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims abstract description 10
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims abstract description 10
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims abstract description 10
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000004471 Glycine Substances 0.000 claims abstract description 10
- 229930010555 Inosine Natural products 0.000 claims abstract description 10
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 claims abstract description 10
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims abstract description 10
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims abstract description 10
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 10
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 10
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 10
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims abstract description 10
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract description 10
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 10
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 10
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims abstract description 10
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000004473 Threonine Substances 0.000 claims abstract description 10
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960005305 adenosine Drugs 0.000 claims abstract description 10
- 235000004279 alanine Nutrition 0.000 claims abstract description 10
- 235000003704 aspartic acid Nutrition 0.000 claims abstract description 10
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960003067 cystine Drugs 0.000 claims abstract description 10
- 235000013922 glutamic acid Nutrition 0.000 claims abstract description 10
- 239000004220 glutamic acid Substances 0.000 claims abstract description 10
- 229940029575 guanosine Drugs 0.000 claims abstract description 10
- 229960003786 inosine Drugs 0.000 claims abstract description 10
- 229960000310 isoleucine Drugs 0.000 claims abstract description 10
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract description 10
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract description 10
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000004474 valine Substances 0.000 claims abstract description 10
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims abstract description 9
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 9
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 9
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract description 8
- 229930182817 methionine Natural products 0.000 claims abstract description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 6
- 229960002685 biotin Drugs 0.000 claims abstract description 3
- 235000020958 biotin Nutrition 0.000 claims abstract description 3
- 239000011616 biotin Substances 0.000 claims abstract description 3
- 229960004799 tryptophan Drugs 0.000 claims description 50
- 238000004519 manufacturing process Methods 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 23
- 239000000243 solution Substances 0.000 claims description 22
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims description 10
- 241000588724 Escherichia coli Species 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 239000011259 mixed solution Substances 0.000 claims description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 239000002054 inoculum Substances 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract description 3
- 239000007836 KH2PO4 Substances 0.000 abstract 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 abstract 1
- 229910052564 epsomite Inorganic materials 0.000 abstract 1
- 239000012092 media component Substances 0.000 abstract 1
- 229910052603 melanterite Inorganic materials 0.000 abstract 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 abstract 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 abstract 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 25
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 229940024606 amino acid Drugs 0.000 description 14
- 235000001014 amino acid Nutrition 0.000 description 14
- 239000002253 acid Substances 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 13
- 235000018977 lysine Nutrition 0.000 description 13
- 229960003121 arginine Drugs 0.000 description 11
- 239000002777 nucleoside Substances 0.000 description 11
- 125000003835 nucleoside group Chemical group 0.000 description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 229960003767 alanine Drugs 0.000 description 8
- 229960005261 aspartic acid Drugs 0.000 description 8
- 229960002449 glycine Drugs 0.000 description 8
- 235000014705 isoleucine Nutrition 0.000 description 8
- 229960003136 leucine Drugs 0.000 description 8
- 235000008729 phenylalanine Nutrition 0.000 description 8
- 229960005190 phenylalanine Drugs 0.000 description 8
- 229960002429 proline Drugs 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 229960002898 threonine Drugs 0.000 description 8
- 235000008521 threonine Nutrition 0.000 description 8
- 229960004441 tyrosine Drugs 0.000 description 8
- 229960004295 valine Drugs 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 229960001153 serine Drugs 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 229960004452 methionine Drugs 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 230000007065 protein hydrolysis Effects 0.000 description 3
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108010075344 Tryptophan synthase Proteins 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229940095539 biotin 3 mg Drugs 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- CJYMGANFUNYUNB-UHFFFAOYSA-N 2-methylthionine Chemical compound CC1=CC=CC=CC=CS1 CJYMGANFUNYUNB-UHFFFAOYSA-N 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical class C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 108010006152 Serine racemase Proteins 0.000 description 1
- 102100035717 Serine racemase Human genes 0.000 description 1
- 101710136122 Tryptophan 2,3-dioxygenase Proteins 0.000 description 1
- 102100040653 Tryptophan 2,3-dioxygenase Human genes 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 229940046414 biotin 1 mg Drugs 0.000 description 1
- 229940085298 biotin 10 mg Drugs 0.000 description 1
- 229940085300 biotin 5 mg Drugs 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000013530 defoamer Substances 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- -1 isoleucine Amino acid Chemical class 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/22—Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
- C12P13/227—Tryptophan
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
技术领域technical field
本发明涉及L-色氨酸生产领域,尤其是一种清液发酵培养基及提高L-色氨酸产量的方法。The invention relates to the field of L-tryptophan production, in particular to a clear liquid fermentation medium and a method for increasing the production of L-tryptophan.
背景技术Background technique
L-色氨酸是人体和动物生命活动中必需的氨基酸之一,对人和动物的生长发育、新陈代谢起着重要的作用,由于其不可替代的生理作用,而被誉为第二必需氨基酸。近年来,由于L-色氨酸商业价值得到越来越多的认可,已广泛应用于医药、食品和饲料等方面,逐渐成为国际市场上发展前景良好、中国市场需求较大的产品。尤其是从二十世纪初开始,这种需求呈现年稳定增长的态势,统计显示:2003年全球L-色氨酸需求量为1180吨,2011年为5600吨,年均复合增长率为21.5%。2003年国内L-色氨酸的总使用量大约为300吨,2011年国内需求总量约为1200吨,年均复合增长率在18.9%。2014年全球L-色氨酸需求量为20000吨,年均复合增长率为53.85%;2015年国内L-色氨酸的总使用量大约为6000吨,同比增长9.1%。L-色氨酸虽已实现工业化生产,但目前产量仍不能满足需要。因此,进一步优化L-色氨酸的生产工艺具有重要意义。与国外先进水平相比,我国L-色氨酸生产存在发酵产酸低、转化率低且副产物多等问题。L-Tryptophan is one of the essential amino acids in human and animal life activities. It plays an important role in the growth, development and metabolism of humans and animals. Because of its irreplaceable physiological role, it is known as the second essential amino acid. In recent years, as the commercial value of L-tryptophan has been more and more recognized, it has been widely used in medicine, food and feed, etc., and has gradually become a product with good development prospects in the international market and a large demand in the Chinese market. Especially since the beginning of the 20th century, this demand has shown a steady annual growth trend. Statistics show that the global demand for L-tryptophan was 1180 tons in 2003 and 5600 tons in 2011, with a compound annual growth rate of 21.5%. . In 2003, the total domestic consumption of L-tryptophan was about 300 tons. In 2011, the total domestic demand was about 1,200 tons, with a compound annual growth rate of 18.9%. In 2014, the global demand for L-tryptophan was 20,000 tons, with a compound annual growth rate of 53.85%; in 2015, the total domestic consumption of L-tryptophan was about 6,000 tons, a year-on-year increase of 9.1%. Although L-tryptophan has been industrially produced, the current output still cannot meet the demand. Therefore, it is of great significance to further optimize the production process of L-tryptophan. Compared with the foreign advanced level, my country's L-tryptophan production has problems such as low fermentation acid production, low conversion rate and many by-products.
目前,L-色氨酸的生产方法主要有:蛋白质水解法、化学合成法、发酵法及酶法。早期主要依靠蛋白质水解法和化学合成法生产L-色氨酸,蛋白质水解法对生产设备要求简单,成本低,但存在污染严重、产品得率低、杂质较多等缺点。化学合成法受到原料来源的限制,并且合成步骤复杂,除需考虑合成工艺条件外,还要考虑异构体的拆分与D-色氨酸异构体的消旋作用,不利于工业化生产。随着科学技术的不断进步,微生物法生产L-色氨酸已经走向实用并且处于主导地位。微生物法大体上可以分为酶法、微生物转化法和直接发酵法。酶法利用微生物中色氨酸生物合成酶系的催化功能生产色氨酸,包括色氨酸酶、色氨酸合成酶、丝氨酸消旋酶等;该法既可以直接加入细胞壁溶解酶使细胞破壁后再使用,也可以将所需的酶固定化后再使用,一般由菌体的培养、菌体的分离洗涤、固定化和反应几个阶段组成;微生物转化法使用葡萄糖作为碳源,同时添加合成色氨酸所需的前体物如邻氨基苯甲酸、吲哚等,利用微生物的色氨酸合成酶系来合成色氨酸;直接发酵法以葡萄糖、甘蔗糖蜜等廉价原料为碳源,利用优良的色氨酸生产菌种来生产色氨酸。随着重组DNA技术在微生物育种中的应用,为优良的色氨酸生产菌株的筛选和产酸水平的提高提供了可靠的技术保障,使微生物直接发酵法生产L-色氨酸成为一种主流的工业化生产方法。At present, the production methods of L-tryptophan mainly include: protein hydrolysis method, chemical synthesis method, fermentation method and enzymatic method. In the early days, L-tryptophan was mainly produced by protein hydrolysis and chemical synthesis. Protein hydrolysis requires simple production equipment and low cost, but has the disadvantages of serious pollution, low product yield, and more impurities. The chemical synthesis method is limited by the source of raw materials, and the synthesis steps are complicated. In addition to the synthesis process conditions, the resolution of isomers and the racemization of D-tryptophan isomers must also be considered, which is not conducive to industrial production. With the continuous advancement of science and technology, the production of L-tryptophan by microbial methods has become practical and is in a dominant position. Microbial methods can be roughly divided into enzymatic methods, microbial transformation methods and direct fermentation methods. The enzymatic method utilizes the catalytic function of tryptophan biosynthetic enzymes in microorganisms to produce tryptophan, including tryptophanase, tryptophan synthetase, serine racemase, etc.; this method can directly add cell wall dissolving enzymes to destroy cells The wall can be reused, or the required enzymes can be immobilized before use, which generally consists of several stages of cell culture, cell separation and washing, immobilization and reaction; the microbial conversion method uses glucose as a carbon source, and at the same time Add the precursors required for the synthesis of tryptophan, such as anthranilic acid, indole, etc., and use the tryptophan synthase system of microorganisms to synthesize tryptophan; the direct fermentation method uses cheap raw materials such as glucose and sugarcane molasses as carbon sources , using excellent tryptophan-producing strains to produce tryptophan. With the application of recombinant DNA technology in microbial breeding, it provides a reliable technical guarantee for the screening of excellent tryptophan production strains and the improvement of acid production level, making the production of L-tryptophan by direct microbial fermentation a mainstream industrial production methods.
目前,L-色氨酸发酵产酸及转化率仍处于较低水平。原因之一是在发酵前期底物葡萄糖同时用于合成L-色氨酸和菌体。细胞生长和L-色氨酸合成之间存在着对碳源和能源的竞争,过高的生物量必然会导致糖酸转化率下降。原因之二是在发酵后期由于细胞比生长速率下降,细胞合成乙酸等副产物,抑制L-色氨酸的合成。原因之三是在发酵中后期,菌体酶活下降较快,导致后期产酸速率下降。At present, the acid production and conversion rate of L-tryptophan are still at a low level. One of the reasons is that the substrate glucose is used to synthesize L-tryptophan and bacteria in the early stage of fermentation. There is competition for carbon and energy sources between cell growth and L-tryptophan synthesis, and excessive biomass will inevitably lead to a decrease in sugar-acid conversion. The second reason is that in the later stage of fermentation, due to the decrease of the specific growth rate of the cells, the cells synthesize acetic acid and other by-products, which inhibit the synthesis of L-tryptophan. The third reason is that in the middle and late stages of fermentation, the enzyme activity of the bacteria decreases rapidly, resulting in a decrease in the rate of acid production in the later stage.
酵母粉成分复杂且存在不稳定因素,导致发酵过程中存在产酸波动及一些不稳定营养成分的抑制现象。此外,酵母粉中含色素等杂质,在后期提取过程中难以去除,直接影响产品质量。以各类氨基酸及核苷对酵母粉进行替代发酵,不稳定营养成分大幅减少,使发酵液趋于稳定,产量波动降低。The composition of yeast powder is complex and there are unstable factors, which lead to fluctuations in acid production and inhibition of some unstable nutrients during the fermentation process. In addition, yeast powder contains impurities such as pigments, which are difficult to remove in the later extraction process, directly affecting product quality. Substituting various amino acids and nucleosides for yeast powder fermentation, the unstable nutrients are greatly reduced, the fermentation broth tends to be stable, and the fluctuation of yield is reduced.
发明内容Contents of the invention
本发明所要解决的技术问题在于提供一种清液发酵培养基。The technical problem to be solved by the present invention is to provide a clear liquid fermentation medium.
本发明所要解决的另一技术问题在于提供一种应用上述清液发酵培养基来提高L-色氨酸产量的方法。Another technical problem to be solved by the present invention is to provide a method for increasing the production of L-tryptophan by using the above-mentioned clear liquid fermentation medium.
为解决上述技术问题,本发明的技术方案是:In order to solve the problems of the technologies described above, the technical solution of the present invention is:
一种清液发酵培养基,组分如下:葡萄糖10g/L,(NH4)2SO4 1-5g/L,肌苷0.1-1g/L,鸟苷0.1-1g/L,腺苷0.01-1g/L,甘氨酸、酪氨酸、天冬氨酸、精氨酸、甲硫氨酸、脯氨酸、胱氨酸、缬氨酸、亮氨酸和丝氨酸各0.1-1g/L,异亮氨酸、苏氨酸、丙氨酸和苯丙氨酸各0.2-2g/L,谷氨酸和赖氨酸各0.5-2g/L,柠檬酸0.1-2g/L,KH2PO4·3H2O 4-8g/L,MgSO4·7H2O 0.5-3g/L,FeSO4·7H2O 1-50mg/L,VB1 1-10mg/L,VB3 1-5mg/L,VB5 1-5mg/L,微量元素溶液0.5-2mL/L,生物素1-10mg/L,氯化胆碱0.1-2g/L,其中,所述微量元素溶液为含有4.5g/LMnSO4·H2O、6.4g/L ZnSO4、4.9g/L Co(NO3)2·6H2O、0.6g/L CuSO4·5H2O的混合溶液;pH至7.0。A serum fermentation medium with the following components: glucose 10g/L, (NH 4 ) 2 SO 4 1-5g/L, inosine 0.1-1g/L, guanosine 0.1-1g/L, adenosine 0.01- 1g/L, 0.1-1g/L each of glycine, tyrosine, aspartic acid, arginine, methionine, proline, cystine, valine, leucine and serine, isoleucine Amino acid, threonine, alanine and phenylalanine each 0.2-2g/L, glutamic acid and lysine each 0.5-2g/L, citric acid 0.1-2g/L, KH 2 PO 4 ·3H 2 O 4-8g/L, MgSO 4 7H 2 O 0.5-3g/L, FeSO 4 7H 2 O 1-50mg/L, V B1 1-10mg/L, V B3 1-5mg/L, V B5 1-5mg/L, trace element solution 0.5-2mL/L, biotin 1-10mg/L, choline chloride 0.1-2g/L, wherein, the trace element solution contains 4.5g/LMnSO 4 ·H 2 Mixed solution of O, 6.4g/L ZnSO 4 , 4.9g/L Co(NO 3 ) 2 ·6H 2 O, 0.6g/L CuSO 4 ·5H 2 O; pH to 7.0.
上述清液发酵培养基用NaOH溶液和/或稀盐酸调pH至7.0,灭菌条件:0.1MPa湿热灭菌20min。The above serum fermentation medium was adjusted to pH 7.0 with NaOH solution and/or dilute hydrochloric acid, and the sterilization conditions were 0.1 MPa damp heat sterilization for 20 minutes.
一种提高L-色氨酸产量的方法,采用色氨酸生产菌经上述清液发酵培养基发酵获得L-色氨酸。A method for improving the production of L-tryptophan, which uses tryptophan-producing bacteria to obtain L-tryptophan by fermenting the above-mentioned clear liquid fermentation medium.
优选的,上述提高L-色氨酸产量的方法,将大肠杆菌按接种量为10%接入上述清液发酵培养基发酵获得L-色氨酸。Preferably, in the method for increasing the production of L-tryptophan, the Escherichia coli is inserted into the above-mentioned clear liquid fermentation medium at an inoculum size of 10% to obtain L-tryptophan for fermentation.
优选的,上述提高L-色氨酸产量的方法,具体步骤为:在37℃、pH为7.0和溶氧为20%-30%条件下,按10%的接种量接入含有清液发酵培养基的30L自动控制发酵罐中,于自动控制发酵罐中培养至对数中后期,通入适当空气,调节适当搅拌转速,控制溶氧为30-50%,通过自动流加25%的氨水控制pH在6.7-7.0,通过流加适量泡敌消泡,并通过流加浓度为800g/L的葡萄糖溶液将残糖控制在15%左右,发酵38h结束,即得。Preferably, the above-mentioned method for increasing the production of L-tryptophan, the specific steps are: at 37°C, pH 7.0 and dissolved oxygen 20%-30%, insert the fermented culture containing clear liquid according to the inoculum size of 10% In the base 30L automatic control fermenter, cultivate in the automatic control fermenter to the middle and late logarithm, introduce appropriate air, adjust the appropriate stirring speed, control the dissolved oxygen to 30-50%, and control it by adding 25% ammonia water automatically. When the pH is 6.7-7.0, the residual sugar is controlled at about 15% by feeding an appropriate amount of foam to defoam, and the glucose solution with a concentration of 800g/L is fed, and the fermentation is completed for 38 hours.
优选的,上述提高L-色氨酸产量的方法,在所述清液发酵培养基中额外随糖流加2g/L氯化胆碱,10g/L KH2PO4·3H2O,2g/L精氨酸,2g/L赖氨酸。Preferably, in the above-mentioned method for increasing the production of L-tryptophan, 2 g/L choline chloride, 10 g/L KH 2 PO 4 ·3H 2 O, 2 g/L L Arginine, 2g/L Lysine.
优选的,上述提高L-色氨酸产量的方法,在所述清液发酵培养基中额外随糖流加2g/L柠檬酸,5g/L KH2PO4·3H2O,2g/L精氨酸,2g/L赖氨酸。Preferably, in the above-mentioned method for increasing the production of L-tryptophan, 2 g/L citric acid, 5 g/L KH 2 PO 4 ·3H 2 O, 2 g/L refined Amino acid, 2g/L lysine.
优选的,上述提高L-色氨酸产量的方法,所述色氨酸生产菌为保藏编号CGMCCNO.11073的大肠杆菌菌种。Preferably, in the above-mentioned method for increasing the production of L-tryptophan, the tryptophan-producing bacteria are Escherichia coli strains with the preservation number CGMCC NO.11073.
本发明结构有如下有益效果:The structure of the present invention has the following beneficial effects:
上述提高L-色氨酸产量的方法,具有如下技术效果:The above-mentioned method for increasing the output of L-tryptophan has the following technical effects:
氨基酸及核苷不含色素等成分,为后续提取工艺及产品色泽及质量提供优势。基于该原理,本技术通过去除发酵培养基中酵母粉,添加各类氨基酸及核苷来提高L-色氨酸发酵产率。Amino acids and nucleosides do not contain pigments and other ingredients, which provide advantages for the subsequent extraction process and product color and quality. Based on this principle, this technology improves the fermentation yield of L-tryptophan by removing yeast powder in the fermentation medium and adding various amino acids and nucleosides.
以各类氨基酸及核苷对酵母粉进行替代发酵,不稳定营养成分大幅减少,使发酵液趋于稳定,产量波动降低。而且氨基酸及核苷不含色素等成分,为后续提取工艺及产品色泽及质量提供优势。基于该原理,本技术通过去除发酵培养基中酵母粉,添加各类氨基酸及核苷来提高L-色氨酸发酵产率及产酸稳定性。Substituting various amino acids and nucleosides for yeast powder fermentation, the unstable nutrients are greatly reduced, the fermentation broth tends to be stable, and the fluctuation of yield is reduced. Moreover, amino acids and nucleosides do not contain pigments and other components, which provide advantages for the subsequent extraction process and product color and quality. Based on this principle, this technology improves the fermentation yield and acid production stability of L-tryptophan by removing yeast powder in the fermentation medium and adding various amino acids and nucleosides.
此方法在不增加额外设备和的情况下,实现了整个发酵周期的稳定性和L-色氨酸产量的提高,及后期提取工艺的简化,适合于工业化生产。The method realizes the stability of the whole fermentation cycle, the increase of the output of L-tryptophan, and the simplification of the extraction process in the later stage without adding additional equipment and equipment, and is suitable for industrial production.
本发明以各类氨基酸及核苷对酵母粉进行替代发酵,不稳定营养成分大幅减少,使发酵液趋于稳定,产量波动降低。而且氨基酸及核苷不含色素等成分,为后续提取工艺及产品色泽及质量提供优势。基于该原理,本技术通过去除发酵培养基中酵母粉,添加各类氨基酸及核苷达到提高L-色氨酸发酵稳定产率的目的。In the present invention, various amino acids and nucleosides are used to substitute yeast powder for fermentation, and unstable nutritional components are greatly reduced, so that the fermentation liquid tends to be stable and the output fluctuation is reduced. Moreover, amino acids and nucleosides do not contain pigments and other components, which provide advantages for the subsequent extraction process and product color and quality. Based on this principle, this technology achieves the purpose of increasing the stable yield of L-tryptophan fermentation by removing yeast powder in the fermentation medium and adding various amino acids and nucleosides.
保藏信息deposit information
分类名词:大肠埃希氏菌Escherichia coliTaxonomic noun: Escherichia coli Escherichia coli
保藏单位名称:中国微生物菌种保藏管理委员会普通微生物中心Name of depository unit: General Microbiology Center of China Committee for the Collection of Microorganisms
保藏单位地址:北京市朝阳区北辰西路1号院3号Address of Preservation Unit: No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing
保藏日期:2015年7月14日Deposit date: July 14, 2015
保藏号:CGMCC NO.11073Deposit number: CGMCC NO.11073
具体实施方式detailed description
下面结合具体实施例对本发明所述技术方案作进一步的说明。The technical solutions of the present invention will be further described below in conjunction with specific embodiments.
实施例1Example 1
一种清液发酵培养基,组分如下:A clear liquid fermentation medium, the components are as follows:
葡萄糖10g/L(分消,0.075MPa湿热灭菌15min),(NH4)2SO4 1.8g/L,肌苷0.1g/L,鸟苷0.1g/L,腺苷0.1g/L,甘氨酸、酪氨酸、天冬氨酸、精氨酸、甲硫氨酸、脯氨酸、胱氨酸、缬氨酸、亮氨酸、丝氨酸各0.1g/L,异亮氨酸、苏氨酸、丙氨酸、苯丙氨酸各0.2g/L,谷氨酸、赖氨酸各0.5g/L,柠檬酸2g/L,KH2PO4·3H2O 7.5g/L,MgSO4·7H2O 1.5g/L,FeSO4·7H2O 6mg/L,VB1 5mg/L,VB3 2mg/L,VB5 2mg/L,微量元素溶液1.2mL/L,生物素3mg/L,氯化胆碱0.5g/L,其中,所述微量元素溶液为含有4.5g/L MnSO4·H2O、6.4g/L ZnSO4、4.9g/L Co(NO3)2·6H2O、0.6g/L CuSO4·5H2O的混合溶液。Glucose 10g/L (disinfection, 0.075MPa damp heat sterilization for 15min), (NH 4 ) 2 SO 4 1.8g/L, inosine 0.1g/L, guanosine 0.1g/L, adenosine 0.1g/L, glycine , tyrosine, aspartic acid, arginine, methionine, proline, cystine, valine, leucine, serine 0.1g/L each, isoleucine, threonine , alanine, phenylalanine each 0.2g/L, glutamic acid, lysine each 0.5g/L, citric acid 2g/L, KH 2 PO 4 3H 2 O 7.5g/L, MgSO 4 . 7H 2 O 1.5g/L, FeSO 4 7H 2 O 6mg/L, V B1 5mg/L, V B3 2mg/L, V B5 2mg/L, trace element solution 1.2mL/L, biotin 3mg/L, Choline chloride 0.5g/L, wherein the trace element solution contains 4.5g/L MnSO 4 ·H 2 O, 6.4g/L ZnSO 4 , 4.9g/L Co(NO 3 ) 2 ·6H 2 O , 0.6g/L CuSO 4 ·5H 2 O mixed solution.
上述清液发酵培养基中各组分按组方量混合后用NaOH溶液和/或稀盐酸调pH至7.0,0.1MPa湿热灭菌20min,即得。The components in the above-mentioned clear liquid fermentation medium are mixed according to the recipe amount, then adjusted to pH 7.0 with NaOH solution and/or dilute hydrochloric acid, and sterilized by 0.1MPa damp heat for 20 minutes.
实施例2Example 2
一种清液发酵培养基,组分如下:A clear liquid fermentation medium, the components are as follows:
葡萄糖10g/L,(NH4)2SO4 1g/L,肌苷0.1g/L,鸟苷0.1g/L,腺苷0.01g/L,甘氨酸、酪氨酸、天冬氨酸、精氨酸、甲硫氨酸、脯氨酸、胱氨酸、缬氨酸、亮氨酸和丝氨酸各1g/L,异亮氨酸、苏氨酸、丙氨酸和苯丙氨酸各2g/L,谷氨酸和赖氨酸各2g/L,柠檬酸0.1g/L,KH2PO4·3H2O 4g/L,MgSO4·7H2O 0.5g/L,FeSO4·7H2O 1mg/L,VB1 1mg/L,VB3 1mg/L,VB5 1mg/L,微量元素溶液0.5mL/L,生物素1mg/L,氯化胆碱0.1g/L,其中,所述微量元素溶液为含有4.5g/LMnSO4·H2O、6.4g/L ZnSO4、4.9g/L Co(NO3)2·6H2O、0.6g/L CuSO4·5H2O的混合溶液。Glucose 10g/L, (NH 4 ) 2 SO 4 1g/L, inosine 0.1g/L, guanosine 0.1g/L, adenosine 0.01g/L, glycine, tyrosine, aspartic acid, arginine 1g/L each of acid, methionine, proline, cystine, valine, leucine and serine, 2g/L each of isoleucine, threonine, alanine and phenylalanine , each of glutamic acid and lysine 2g/L, citric acid 0.1g/L, KH 2 PO 4 3H 2 O 4g/L, MgSO 4 7H 2 O 0.5g/L, FeSO 4 7H 2 O 1mg /L, V B1 1mg/L, V B3 1mg/L, V B5 1mg/L, trace element solution 0.5mL/L, biotin 1mg/L, choline chloride 0.1g/L, wherein, the trace element The solution was a mixed solution containing 4.5g/LMnSO 4 ·H 2 O, 6.4g/L ZnSO 4 , 4.9g/L Co(NO 3 ) 2 ·6H 2 O, and 0.6g/L CuSO 4 ·5H 2 O.
上述清液发酵培养基中各组分按组方量混合后用NaOH溶液和/或稀盐酸调pH至7.0,0.1MPa湿热灭菌20min,即得。The components in the above-mentioned clear liquid fermentation medium are mixed according to the recipe amount, then adjusted to pH 7.0 with NaOH solution and/or dilute hydrochloric acid, and sterilized by 0.1MPa damp heat for 20 minutes.
实施例3Example 3
一种清液发酵培养基,组分如下:A clear liquid fermentation medium, the components are as follows:
葡萄糖10g/L,(NH4)2SO4 5g/L,肌苷1g/L,鸟苷1g/L,腺苷1g/L,甘氨酸、酪氨酸、天冬氨酸、精氨酸、甲硫氨酸、脯氨酸、胱氨酸、缬氨酸、亮氨酸和丝氨酸各0.1g/L,异亮氨酸、苏氨酸、丙氨酸和苯丙氨酸各0.2g/L,谷氨酸和赖氨酸各0.5g/L,柠檬酸2g/L,KH2PO4·3H2O8g/L,MgSO4·7H2O 3g/L,FeSO4·7H2O 50mg/L,VB1 10mg/L,VB3 5mg/L,VB5 5mg/L,微量元素溶液2mL/L,生物素10mg/L,氯化胆碱2g/L,其中,所述微量元素溶液为含有4.5g/L MnSO4·H2O、6.4g/L ZnSO4、4.9g/L Co(NO3)2·6H2O、0.6g/L CuSO4·5H2O的混合溶液。Glucose 10g/L, (NH 4 ) 2 SO 4 5g/L, inosine 1g/L, guanosine 1g/L, adenosine 1g/L, glycine, tyrosine, aspartic acid, arginine, methyl 0.1g/L each of thionine, proline, cystine, valine, leucine and serine, 0.2g/L each of isoleucine, threonine, alanine and phenylalanine, Glutamic acid and lysine each 0.5g/L, citric acid 2g/L, KH 2 PO 4 3H 2 O 8g/L, MgSO 4 7H 2 O 3g/L, FeSO 4 7H 2 O 50mg/L, V B1 10mg/L, V B3 5mg/L, V B5 5mg/L, trace element solution 2mL/L, biotin 10mg/L, choline chloride 2g/L, wherein, the trace element solution contains 4.5g A mixed solution of /L MnSO 4 ·H 2 O, 6.4g/L ZnSO 4 , 4.9g/L Co(NO 3 ) 2 ·6H 2 O, 0.6g/L CuSO 4 ·5H 2 O.
上述清液发酵培养基中各组分按组方量混合后用NaOH溶液和/或稀盐酸调pH至7.0,0.1MPa湿热灭菌20min,即得。The components in the above-mentioned clear liquid fermentation medium are mixed according to the recipe amount, and then the pH is adjusted to 7.0 with NaOH solution and/or dilute hydrochloric acid, and sterilized by 0.1MPa damp heat for 20 minutes.
实施例4Example 4
一种清液发酵培养基,组分如下:A clear liquid fermentation medium, the components are as follows:
葡萄糖10g/L,(NH4)2SO4 3g/L,肌苷0.5g/L,鸟苷0.5g/L,腺苷0.5g/L,甘氨酸、酪氨酸、天冬氨酸、精氨酸、甲硫氨酸、脯氨酸、胱氨酸、缬氨酸、亮氨酸和丝氨酸各0.5g/L,异亮氨酸、苏氨酸、丙氨酸和苯丙氨酸各1g/L,谷氨酸和赖氨酸各1.5g/L,柠檬酸1g/L,KH2PO4·3H2O 6g/L,MgSO4·7H2O 2g/L,FeSO4·7H2O 10mg/L,VB1 3mg/L,VB3 2mg/L,VB54mg/L,微量元素溶液1mL/L,生物素5mg/L,氯化胆碱1g/L,其中,所述微量元素溶液为含有4.5g/L MnSO4·H2O、6.4g/L ZnSO4、4.9g/L Co(NO3)2·6H2O、0.6g/L CuSO4·5H2O的混合溶液。Glucose 10g/L, (NH 4 ) 2 SO 4 3g/L, inosine 0.5g/L, guanosine 0.5g/L, adenosine 0.5g/L, glycine, tyrosine, aspartic acid, arginine acid, methionine, proline, cystine, valine, leucine and serine each 0.5g/L, each of isoleucine, threonine, alanine and phenylalanine 1g/L L, glutamic acid and lysine each 1.5g/L, citric acid 1g/L, KH 2 PO 4 3H 2 O 6g/L, MgSO 4 7H 2 O 2g/L, FeSO 4 7H 2 O 10mg /L, V B1 3mg/L, V B3 2mg/L, V B5 4mg/L, trace element solution 1mL/L, biotin 5mg/L, choline chloride 1g/L, wherein, the trace element solution is A mixed solution containing 4.5g/L MnSO 4 ·H 2 O, 6.4g/L ZnSO 4 , 4.9g/L Co(NO 3 ) 2 ·6H 2 O, and 0.6g/L CuSO 4 ·5H 2 O.
上述清液发酵培养基中各组分按组方量混合后用NaOH溶液和/或稀盐酸调pH至7.0,0.1MPa湿热灭菌20min,即得。The components in the above-mentioned clear liquid fermentation medium are mixed according to the recipe amount, then adjusted to pH 7.0 with NaOH solution and/or dilute hydrochloric acid, and sterilized by 0.1MPa damp heat for 20 minutes.
实施例5Example 5
一种提高L-色氨酸产量的方法,具体步骤如下:A method for improving the output of L-tryptophan, the specific steps are as follows:
采用的大肠埃希氏菌(保藏于中国普通微生物菌种保藏中心,保藏编号:CGMCCNO.11073);培养基为清液发酵培养基[葡萄糖10g/L(分消,0.075MPa湿热灭菌15min),(NH4)2SO4 1.8g/L,肌苷0.1g/L,鸟苷0.1g/L,腺苷0.1g/L,甘氨酸、酪氨酸、天冬氨酸、精氨酸、甲硫氨酸、脯氨酸、胱氨酸、缬氨酸、亮氨酸、丝氨酸各0.1g/L,异亮氨酸、苏氨酸、丙氨酸、苯丙氨酸各0.2g/L,谷氨酸、赖氨酸各0.5g/L,柠檬酸2g/L,KH2PO4·3H2O 7.5g/L,MgSO4·7H2O 1.5g/L,FeSO4·7H2O 6mg/L,VB1 5mg/L,VB3 2mg/L,VB5 2mg/L,微量元素1.2mL/L(微量元素为含有4.5g/L MnSO4·H2O、6.4g/L ZnSO4、4.9g/L Co(NO3)2·6H2O、0.6g/L CuSO4·5H2O的混合溶液),生物素3mg/L,氯化胆碱0.5g/L,用NaOH和盐酸调pH至7.0。灭菌条件:0.1MPa湿热灭菌20min];培养方法:将菌种接入种子培养基[葡萄糖40g/L,(NH4)2SO4 3g/L,肌苷0.1g/L,鸟苷0.1g/L,腺苷0.1g/L,甘氨酸、酪氨酸、天冬氨酸、精氨酸、甲硫氨酸、脯氨酸、胱氨酸、缬氨酸、亮氨酸、丝氨酸各0.1g/L,异亮氨酸、苏氨酸、丙氨酸、苯丙氨酸各0.2g/L,谷氨酸、赖氨酸各0.5g/L,柠檬酸2g/L,KH2PO4 6g/L,MgSO4·7H2O 1.6g/L,FeSO4·7H2O 10mg/L,VB1 5mg/L,VB3 2mg/L,VB5 2mg/L,微量元素1mL/L,生物素2mg/L],接种量为10%;在37℃、pH为7.0和溶氧为20%-30%条件下于5L自动控制发酵罐中培养12h至对数中后期,按10%的接种量接入含有上述清液发酵培养基的30L自动控制发酵罐中,通入适当空气,调节适当搅拌转速,控制溶氧为30-50%,通过自动流加25%的氨水控制pH在6.7-7.0,通过流加适量泡敌消泡剂消泡,并通过流加浓度为800g/L的葡萄糖溶液将残糖控制在15%左右,发酵38h结束;进行两批平行实验。放罐时,L-色氨酸的产量分别为38.6g/L、38.2g/L,分别比对照实验(两批实验)(L-色氨酸产量分别为34.2g/L、35.5g/L)提高了12.86%和7.61%,产酸稳定性较高,产量波动小。The Escherichia coli used (preserved in China General Microorganism Culture Collection Center, preservation number: CGMCCNO.11073); the culture medium is clear liquid fermentation medium [glucose 10g/L (divided and eliminated, 0.075MPa damp heat sterilization for 15min) , (NH 4 ) 2 SO 4 1.8g/L, inosine 0.1g/L, guanosine 0.1g/L, adenosine 0.1g/L, glycine, tyrosine, aspartic acid, arginine, methyl Thionine, proline, cystine, valine, leucine, serine each 0.1g/L, isoleucine, threonine, alanine, phenylalanine each 0.2g/L, Glutamic acid and lysine each 0.5g/L, citric acid 2g/L, KH 2 PO 4 3H 2 O 7.5g/L, MgSO 4 7H 2 O 1.5g/L, FeSO 4 7H 2 O 6mg /L, V B1 5mg/L, V B3 2mg/L, V B5 2mg/L, trace elements 1.2mL/L (trace elements contain 4.5g/L MnSO 4 ·H 2 O, 6.4g/L ZnSO 4 , 4.9g/L Co(NO 3 ) 2 ·6H 2 O, 0.6g/L CuSO 4 ·5H 2 O mixed solution), biotin 3mg/L, choline chloride 0.5g/L, adjusted with NaOH and hydrochloric acid pH to 7.0. Sterilization conditions: 0.1MPa damp heat sterilization for 20min]; culture method: insert the bacteria into the seed medium [glucose 40g/L, (NH 4 ) 2 SO 4 3g/L, inosine 0.1g/L, guanosine 0.1 g/L, adenosine 0.1g/L, glycine, tyrosine, aspartic acid, arginine, methionine, proline, cystine, valine, leucine, serine 0.1 each g/L, isoleucine, threonine, alanine, phenylalanine each 0.2g/L, glutamic acid, lysine each 0.5g/L, citric acid 2g/L, KH 2 PO 4 6g/L, MgSO 4 7H 2 O 1.6g/L, FeSO 4 7H 2 O 10mg/L, V B1 5mg/L, V B3 2mg/L, V B5 2mg/L, trace elements 1mL/L, biological 2 mg/L], the inoculum size is 10%; at 37°C, pH is 7.0 and dissolved oxygen is 20%-30%, cultivate in a 5L automatic control fermenter for 12h to the middle and late logarithm, and inoculate with 10% Put the amount into the 30L automatic control fermenter containing the above-mentioned clear liquid fermentation medium, introduce appropriate air, adjust the appropriate stirring speed, control the dissolved oxygen to 30-50%, and control the pH at 6.7-5% by automatically adding 25% ammonia water 7.0, defoaming by adding an appropriate amount of foam enemy defoamer, and controlling the residual sugar at about 15% by feeding a glucose solution with a concentration of 800g/L, and the fermentation is over for 38 hours; two batches of parallel experiments were carried out. When putting tank, the output of L-tryptophan is respectively 38.6g/L, 38.2g/L, compared with control experiment (two batches of experiments) respectively (L-tryptophan output is respectively 34.2g/L, 35.5g/L ) increased by 12.86% and 7.61%, the acid production stability is high, and the yield fluctuation is small.
实施例6Example 6
采用的菌株为大肠杆菌;培养基为清液发酵培养基(同实施例5)中随糖流加2g/L氯化胆碱,10g/L KH2PO4·3H2O,2g/L精氨酸,2g/L赖氨酸;培养方法同实施例5。进行两批平行实验。放罐时,L-色氨酸的产量分别为40.6g/L、41.0g/L,分别比对照实验(两批实验)(L-色氨酸产量分别为34.2g/L、35.5g/L)提高了18.71%和15.49%,产酸稳定性较高,产量波动小。The bacterial strain that adopts is Escherichia coli; Culture medium is that 2g/L choline chloride is added with sugar flow in the supernatant liquid fermentation culture medium (same as embodiment 5), 10g/L KH 2 PO 4 3H 2 O, 2g/L refined Amino acid, 2g/L lysine; Culture method is with embodiment 5. Two parallel experiments were performed. When putting tank, the output of L-tryptophan is respectively 40.6g/L, 41.0g/L, compared with control experiment (two batches of experiments) respectively (L-tryptophan output is respectively 34.2g/L, 35.5g/L ) increased by 18.71% and 15.49%, the stability of acid production was high, and the yield fluctuation was small.
实施例7Example 7
采用的菌株为大肠杆菌;培养基为清液发酵培养基(同实施例5)中随糖流加2g/L柠檬酸,5g/LKH2PO4·3H2O,2g/L精氨酸,2g/L赖氨酸;培养方法同实施例5。进行两批平行实验。放罐时,L-色氨酸的产量分别为41.6g/L、41.9g/L,分别比对照实验(两批实验)(L-色氨酸产量分别为34.2g/L、35.5g/L)提高了21.64%和18.03%,产酸稳定性较高,产量波动小。The bacterial strain that adopts is Escherichia coli; Culture medium is to add 2g/L citric acid, 5g/LKH 2 PO 4 3H 2 O, 2g/L arginine with sugar flow in clear liquid fermentation medium (same as embodiment 5), 2g/L lysine; Culture method is with embodiment 5. Two parallel experiments were performed. When putting tank, the output of L-tryptophan is respectively 41.6g/L, 41.9g/L, compared with control experiment (two batches of experiments) respectively (L-tryptophan output is respectively 34.2g/L, 35.5g/L ) increased by 21.64% and 18.03%, the stability of acid production was high, and the yield fluctuation was small.
可见,通过去除现有培养基中的酵母粉,并在培养基中添加特定的氨基酸及核苷达到替代作用,使其在培养基中的浓度为0.1-0.5g/L,并在发酵中后期流加营养物质,最终获得高产量的L-色氨酸,其中,It can be seen that by removing the yeast powder in the existing medium and adding specific amino acids and nucleosides to the medium to achieve a substitution effect, the concentration in the medium is 0.1-0.5g/L, and in the middle and late stages of fermentation Feed feed nutrients, and finally obtain high-yield L-tryptophan, wherein,
所述各类氨基酸包括:甘氨酸、酪氨酸、天冬氨酸、精氨酸、甲硫氨酸、脯氨酸、胱氨酸、缬氨酸、异亮氨酸、亮氨酸、苏氨酸、丙氨酸、苯丙氨酸、谷氨酸和赖氨酸;The various amino acids include: glycine, tyrosine, aspartic acid, arginine, methionine, proline, cystine, valine, isoleucine, leucine, threonine acid, alanine, phenylalanine, glutamic acid and lysine;
所述各类核苷包括:鸟苷、肌苷、腺苷;The various nucleosides include: guanosine, inosine, adenosine;
所述流加营养物质包括:柠檬酸、KH2PO4·3H2O、精氨酸、赖氨酸。The fed-in nutrients include: citric acid, KH 2 PO 4 ·3H 2 O, arginine, and lysine.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above is only a preferred embodiment of the present invention, it should be pointed out that, for those of ordinary skill in the art, without departing from the principle of the present invention, some improvements and modifications can also be made, and these improvements and modifications can also be made. It should be regarded as the protection scope of the present invention.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611188743.1A CN106755159A (en) | 2016-12-21 | 2016-12-21 | A kind of liquor fermentation culture medium and the method for improving L tryptophan yield |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611188743.1A CN106755159A (en) | 2016-12-21 | 2016-12-21 | A kind of liquor fermentation culture medium and the method for improving L tryptophan yield |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106755159A true CN106755159A (en) | 2017-05-31 |
Family
ID=58896336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611188743.1A Pending CN106755159A (en) | 2016-12-21 | 2016-12-21 | A kind of liquor fermentation culture medium and the method for improving L tryptophan yield |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106755159A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109182407A (en) * | 2018-09-21 | 2019-01-11 | 江苏澳创生物科技有限公司 | A kind of tryptophan preparation method and its fermentation medium and tryptophan that use fermentation special nutritional member |
CN109517858A (en) * | 2018-12-17 | 2019-03-26 | 新疆阜丰生物科技有限公司 | A method of production and extraction L-Trp |
CN109593801A (en) * | 2018-12-17 | 2019-04-09 | 新疆阜丰生物科技有限公司 | A kind of technique of fermenting and producing L-Trp |
CN109609567A (en) * | 2018-12-30 | 2019-04-12 | 新疆阜丰生物科技有限公司 | A kind of green production method of L-tryptophan using thalline protease hydrolyzate instead of yeast powder |
CN112553281A (en) * | 2020-12-28 | 2021-03-26 | 嘉必优生物技术(武汉)股份有限公司 | Fermentation medium and application thereof |
CN114381477A (en) * | 2020-10-19 | 2022-04-22 | 江苏元易邦生物科技有限公司 | Method for improving yield and sugar-acid conversion rate of L-tryptophan fermentation process |
CN116606875A (en) * | 2023-04-20 | 2023-08-18 | 黑龙江金象生化有限责任公司 | A gene mutator strain and its application in the screening of heat-resistant tryptophan production strains |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5164307A (en) * | 1987-01-23 | 1992-11-17 | Ajinomoto Co., Inc. | Process for producing L-amino acids by fermentation |
CN102168118A (en) * | 2011-01-31 | 2011-08-31 | 安徽丰原发酵技术工程研究有限公司 | Method for increasing fermentation output of tryptophan |
CN102242165A (en) * | 2011-05-26 | 2011-11-16 | 上海应用技术学院 | Method for producing high molecular weight sodium hyaluronate through fermentation and culture medium utilized by same |
CN104878051A (en) * | 2015-05-25 | 2015-09-02 | 天津科技大学 | Method for improving fermentation yield of L-isoleucine through adding choline |
CN105316371A (en) * | 2015-10-23 | 2016-02-10 | 安徽丰原发酵技术工程研究有限公司 | Tryptophan fermentation yield increase method |
-
2016
- 2016-12-21 CN CN201611188743.1A patent/CN106755159A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5164307A (en) * | 1987-01-23 | 1992-11-17 | Ajinomoto Co., Inc. | Process for producing L-amino acids by fermentation |
CN102168118A (en) * | 2011-01-31 | 2011-08-31 | 安徽丰原发酵技术工程研究有限公司 | Method for increasing fermentation output of tryptophan |
CN102242165A (en) * | 2011-05-26 | 2011-11-16 | 上海应用技术学院 | Method for producing high molecular weight sodium hyaluronate through fermentation and culture medium utilized by same |
CN104878051A (en) * | 2015-05-25 | 2015-09-02 | 天津科技大学 | Method for improving fermentation yield of L-isoleucine through adding choline |
CN105316371A (en) * | 2015-10-23 | 2016-02-10 | 安徽丰原发酵技术工程研究有限公司 | Tryptophan fermentation yield increase method |
Non-Patent Citations (1)
Title |
---|
王东阳等: "L-色氨酸中试生产研究", 《现代化工》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109182407A (en) * | 2018-09-21 | 2019-01-11 | 江苏澳创生物科技有限公司 | A kind of tryptophan preparation method and its fermentation medium and tryptophan that use fermentation special nutritional member |
CN109517858A (en) * | 2018-12-17 | 2019-03-26 | 新疆阜丰生物科技有限公司 | A method of production and extraction L-Trp |
CN109593801A (en) * | 2018-12-17 | 2019-04-09 | 新疆阜丰生物科技有限公司 | A kind of technique of fermenting and producing L-Trp |
CN109609567A (en) * | 2018-12-30 | 2019-04-12 | 新疆阜丰生物科技有限公司 | A kind of green production method of L-tryptophan using thalline protease hydrolyzate instead of yeast powder |
CN109609567B (en) * | 2018-12-30 | 2022-05-03 | 新疆阜丰生物科技有限公司 | Green production method of L-tryptophan by using mycoprotein enzymolysis liquid to replace yeast powder |
CN114381477A (en) * | 2020-10-19 | 2022-04-22 | 江苏元易邦生物科技有限公司 | Method for improving yield and sugar-acid conversion rate of L-tryptophan fermentation process |
CN112553281A (en) * | 2020-12-28 | 2021-03-26 | 嘉必优生物技术(武汉)股份有限公司 | Fermentation medium and application thereof |
CN116606875A (en) * | 2023-04-20 | 2023-08-18 | 黑龙江金象生化有限责任公司 | A gene mutator strain and its application in the screening of heat-resistant tryptophan production strains |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106755159A (en) | A kind of liquor fermentation culture medium and the method for improving L tryptophan yield | |
CN109504719B (en) | Method for improving acid production rate and extraction rate of glutamic acid | |
CN102174449B (en) | Method for producing high-yield gamma-propalanine and application thereof | |
WO2020140388A1 (en) | Glutamic acid green clean fermentation process | |
CN101955901B (en) | Corynebacterium glutamicum and method for preparing L-ornithine and salts thereof by using same | |
CN112322673B (en) | Fermentation method of glutamic acid | |
CN104726510B (en) | A kind of method of preparing lysine through fermentation | |
CN101586131B (en) | Method for preparing L-aspartic acid | |
CN103215322A (en) | Fermentation method for increasing yield of L-valine | |
CN101705262A (en) | New process for improving fermentation and acid production rate of glutamic acid temperature sensitive mutant by utilizing glycine betaine | |
CN113278661A (en) | Fermentation medium and fermentation method for increasing glutamic acid yield | |
CN105779522B (en) | A kind of microbial enzyme conversion method produces the method for L 4 hydroxyisoleucine | |
CN100415893C (en) | Method for preparing L-glutaminic acid | |
CN115505607A (en) | Method for producing L-glutamine by fermentation | |
CN102899372A (en) | Method for producing cyclic adenosine monophosphate through fermentation by controlling dissolved oxygen in two stages | |
CN104561076A (en) | Methods for constructing and fermenting L-serine high-yielding recombinant corynebacterium glutamicum | |
CN108285914B (en) | Fermentation process of L-tryptophan | |
CN112029683A (en) | A kind of glucose control technology for improving L-isoleucine yield | |
CN109609566B (en) | Method for improving threonine yield | |
CN114438145B (en) | Method for producing L-valine through fermentation | |
CN112251476B (en) | Production method of L-phenylalanine | |
CN102051386A (en) | Method for producing organic acid at high production rate through fermentation of intermittent backflow cells | |
CN112662713B (en) | Culture medium for producing L-lysine by high-density fermentation and method thereof | |
CN108048496A (en) | The fermentation method for producing of CoQ10 and the high-content CoQ10 being prepared by it | |
CN107760734A (en) | A kind of method and its application of improving threonine yield |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170531 |